Arrivent Biopharma, Inc. <AVBP.O>: H.C. Wainwright Raises Target Price To $47 From $44
AVBP•Related News
Suzano posts investor presentation outlining strategy, financial management and sustainability priorities
SUZ•
Visteon declares quarterly dividend of $0.38 per share
VC•
US Stocks-Nasdaq futures gain as tech stocks climb
QQQ•
Workday, Inc. <WDAY.O>: BTIG Cuts to Neutral From Buy
WDAY•
NRx Pharmaceuticals schedules conference call on quarterly results and corporate update
NRXP•